Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 2Withdrawn 1Unknown 1Suspended 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioma 1Brain Neoplasms 1

Interventions

Bevacizumab 4Specimen Handling 3Magnetic Resonance Spectroscopy 2Everolimus 2Biopsy 2trametinib 1relatlimab 1pembrolizumab 1lutetium Lu 177 dotatate 1fluoromisonidazole 1fludarabine phosphate 1antineoplaston AS 2-1 1antineoplaston A10 1aldesleukin 1X-Rays 1Transcranial Magnetic Stimulation 1TPI-287 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Nivolumab 1Niacinamide 1Niacin 1Metformin 1Mental Status and Dementia Tests 1Magnetic Resonance Imaging 1Lomustine 1Lasers, Solid-State 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Transcranial Magnetic Stimulation × CNS × Clear all
NCT04209023 2022-09-28

The Use of Navigated Transcranial Magnetic Stimulation (nTMS) in the Inhibition of Neurofunctional Regions of Interest

Neurological Associates of West Los Angeles

Phase NA Suspended
10 enrolled
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡